CURE 51

🧡 Our very own Yann featured on Science Illustrated!

Yann is the Manager of our Patients’ Committee, where he helps ensure that patient voices are represented in our Rosalind Study. He works closely with exceptional survivors, advocates, doctors and researchers to bring lived experience into the conversation that helps shape the future of cancer research.

Diagnosed with metastatic pancreatic cancer at just 35 years old, Yann survived against extraordinary odds. Today, nearly a decade later, he continues to turn that experience into action for other patients.

Thank you Yann, for your dedication, your optimism and your commitment to helping us better understand exceptional survival.

🔗 Want to read the full article? Link in the first comment!

Camille Moses, Dave Bolton, Ryan Dwars, Brooke Hammond Dwars, Brad Sluiter, Pamela Deasy

📄 Until All Survive: We started with a blank page.

We have spent months researching, debating and building a new project from the ground up. Dozens of conversations around one question: how do we create space for patient voices in a way that truly reflects their experience?

We are almost ready to share it with you!

And before we do, we want to hear from you. What are you most excited about?

🧡 Portraits of exceptional survivors
🧡 Thematic articles on sport, nutrition, caregiving and travel during treatment.
🧡 Being part of a community of like-minded people
🧡 Something else - tell us below!

Coming soon! Until All Survive.

💬 What’s one stereotype about cancer care you’d like to debunk?

Our Medical Director, Dr. Adrien Paix, is opening the conversation. We’d love to hear your perspective too!
👇 Share yours in the comments below

Pamela Deasy Camille Moses

🧡 Which team are you today?

💬 Show us with a reaction or Share your thoughts in the comments!

Until all survive.
Brooke Hammond Dwars Ryan Dwars

🇪🇺 European Week Against Cancer: the people and discoveries shaping the future of oncology

Every part of our research tries to answer a question: why do some patients respond differently to treatment? What can exceptional survivors teach us? How can science help more people live longer, fuller lives after cancer? Behind these questions are people: patients, families, clinicians, scientists, advocates. Over the past months, we shared moments from this journey: survivor experiences, the science behind our Rosalind Study and the technologies opening new perspectives for oncology.

📚 For European Week Against Cancer, we brought together 7 posts that reflect what inspires our work every day: understanding exceptional survivorship to help shape the future of cancer care.

Until all survive.

1. What is the hardest part of being a cancer advocate? https://www.facebook.com/share/r/1FUx9EpV4Q/

2. The hidden cost of survival: https://www.facebook.com/share/r/1NT1HEoeBk/

3. Why our scientific approach feels positive https://www.facebook.com/share/v/1HyX1UEW4x/

4. When determination wins: https://www.facebook.com/CURE51/posts/pfbid0cZL2pzq99rz6QSc7KqEymx2HgkP4a7bwoaN7hCvdgCGmX7iGkyLBNxTSAWkfATPtl

5. Be your own advocate: https://www.facebook.com/share/r/1RHLc36Ja8/

6. How we like to stay in good health: https://www.facebook.com/CURE51/posts/pfbid02E3B71sJSRSLCM95EDN1FupkRXJasKdqzkcn6dqp6DuSahRjTPf5PaFU7WPHyVbBal

7. A new way of understanding cancer: https://www.facebook.com/CURE51/posts/pfbid0kVYHy3HRJSdjFge8TCLLyQefRvZwprvGuvEd3Mor7PJdEP1Xib3whx5NgaPjn2N5l

🧠 Spatial biology is changing how we understand glioblastoma

Glioblastoma is a complex system composed of five biological regions, each defined by its own cellular architecture, behavior and response patterns.
We map it as a living system: observing which cells are present, how they are arranged, what surrounds them and how these relationships evolve across different patient profiles, including exceptional survivors.

➡ Swipe right to learn more!
Until All Survive.

🩺 A central role in our Rosalind Study: meet Dr. Adrien Paix, our Medical Director!

A Radiation oncologist, Adrien’s role guides the scientific direction of our study and ensures that what we build remains deeply meaningful for patients. He helps us connect rigorous medical research with real-life experiences, so each step of the study stays scientifically solid and human-centered.

Adrien’s guidance allows us to move forward with confidence while staying grounded in what truly matters: improving understanding of cancer journeys and learning from them in a responsible and thoughtful way.

💬 Do you have questions for Dr. Adrien Paix? Leave them in the comments!